Skip to search.
 FTSE 100 Up 0.68%

Alkermes plc (ALKS)

-NasdaqGS
43.42 Up 0.54(1.26%) 24 May 21:00
Prev Close:42.88
Open:43.20
Bid:42.00 x 300
Ask:N/A
1y Target Est:44.40
Beta:2.01688
Earnings Date:28 Jul - 1 Aug (Est.)
Day's Range:42.81 - 44.28
52wk Range:27.14 - 80.71
Volume:1,054,454
Avg Vol (3m):1,459,340
Market Cap:6.56b
P/E (ttm):N/A
EPS (ttm):-1.83
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSUp 1.26%6.56b
LLYUp 1.23%79.13b
GSKUp 1.67%103.74b
ABTUp 1.63%55.80b

Key Statistics

Forward P/E (1 yr):241.22
P/S (ttm):10.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.29
Quarterly EPS Est (Jun-16) :-0.10
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):6.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback